News

Xiwang group china
Xiwang group china

Xiwang Group China stands as one of the most influential and diversified enterprise groups in China’s modern industrial landscape, with a development history spanning nearly four decades. Rooted in solid industrial operations and national strategies, Xiwang Group has evolved from a local enterprise into a national flagship, operating across corn deep processing, high‑end special steel, food, pharmaceuticals, international trade and modern logistics. Known officially as Xiwang Group Co Ltd, the group is widely recognized in both domestic and global markets as Xiwang Group Company, a name that represents scale, technology and stable industrial strength.Headquartered in Zouping, Shandong Province, Shandong Xiwang Group enjoys a superior geographical location and complete industrial supporting facilities, which have laid a solid foundation for its long‑term development. Since its establishment, the group has adhered to dual core drives: agricultural and sideline products deep processing and high‑performance metal materials. With total assets exceeding 50 billion yuan and more than 16,000 employees, Xiwang Group Co Ltd has built a complete industrial chain covering raw material bases, intelligent production, quality control, research and development, sales and after‑sales service, making it a model of large‑scale private enterprise in China.A key pillar supporting the group’s health industry layout is Xiwang pharmaceutical, a professional sector focusing on pharmaceutical raw materials, nutritional chemicals and bio‑based products. As an important part of the group’s industrial structure, Xiwang pharmaceutical co ltd specializes in pharmaceutical‑grade glucose, crystalline fructose, inositol and other high value‑added products, which are widely used in injections, health products, food additives and biological preparations. These products meet strict international certification standards such as GMP, ISO and HALAL, enabling Xiwang Group China to gain stable customers and high reputation in global pharmaceutical and food markets.The industrial layout of Shandong Xiwang Group is both focused and extensive. Its corn deep processing sector has an annual processing capacity of millions of tons, producing edible glucose, medicinal glucose, fructose, corn oil, maltodextrin and sodium gluconate. Among them, corn oil and starch sugar products have leading market shares in China, and are exported to more than 50 countries and regions. This business system makes Xiwang Group not only a food and nutrition supplier, but also a key player supporting China’s grain processing industry and agricultural modernization.As a comprehensive group, Xiwang Group Company has always maintained standardized corporate governance and a multi‑level capital platform. It holds several listed companies and high‑tech enterprises, covering food, special steel, sugar and other fields. These platforms provide strong financial and technical support for the group’s technological innovation, industrial upgrading and global expansion. Meanwhile, the group’s international business enables Xiwang Group Co Ltd to maintain close cooperation with global brands in supply chain, technology research and product certification, further enhancing the international influence of Xiwang Group China.In the medical and health field, Xiwang pharmaceutical and Xiwang pharmaceutical co ltd continue to invest in research and development, focusing on green production, high purity and safety. Their products are widely used in clinical drugs, health food and sports nutrition, perfectly matching the global trend of pursuing healthy life. This layout enables the group to form a synergistic effect between food and medicine, and establishes a differentiated competitive advantage that is difficult to replicate.Looking to the future, Shandong Xiwang Group will continue to focus on its main industries, strengthen technological innovation, promote green and low‑carbon development, and deepen its layout in high‑end manufacturing, health consumption and international trade. As a representative enterprise of Xiwang Group China, the group will uphold the values of health, integrity and innovation, provide safer and higher‑quality products for global customers, and strive to become a world‑class integrated industrial group.From a local factory to a national giant and then to an international brand, Xiwang Group has always maintained steady progress. Whether referred to as Xiwang Group Co Ltd, Xiwang Group Company or Shandong Xiwang Group, it represents the same persistent pursuit of quality, technology and responsibility. With the strong support of Xiwang pharmaceutical and Xiwang pharmaceutical co ltd, the group will continue to move forward on the path of high‑quality development and write a new chapter of China’s industrial power.

Shandong Xiwang Group: Empowering the High-Quality Development of the Grain and Oil Industry Across the Entire Value Chain; A Zero-Carbon Strategy Paves the Way for a New Journey of Green Transformation.
Shandong Xiwang Group: Empowering the High-Quality Development of the Grain and Oil Industry Across the Entire Value Chain; A Zero-Carbon Strategy Paves the Way for a New Journey of Green Transformation.

In March 2026, Shandong Xiwang Group was greeted with a series of good news: its subsidiary Xiwang Food launched a new product, Platinum NMN Capsules. With raw materials certified by both GRAS (Generally Recognized as Safe) and CGMP (Current Good Manufacturing Practice), and backed by international authoritative testing, the product quickly became a new favorite in the sports nutrition market. Meanwhile, the group is fully advancing the "Annual 1 Million Ton Corn Processing Circular Economy (Zero-Carbon) Industrial Park Project" in Huaxian County, Henan Province, driving industrial upgrading through green technological innovation and demonstrating the responsibility and mission of a leading enterprise in the industry.Founded in 1986, Shandong Xiwang Group has developed into a large national enterprise group integrating corn deep processing, special steel, logistics, international trade and other industries after more than 30 years of development. In the field of corn deep processing, Xiwang has established a unique full-industry-chain development model, with an annual corn processing capacity of 3 million tons, leading the country in intensive scale. It supplies 85% of the domestic market's pharmaceutical glucose, 50% of edible glucose, and 95% of crystalline fructose, making it the largest production base of edible glucose, pharmaceutical glucose and corn oil in Asia, with an annual output of 600,000 tons of corn oil and a domestic market share of 60%.As the core segment of the group, Xiwang Food adheres to the demonstration and leading role of "China Good Grain and Oil". Its raw materials are selected from non-genetically modified corn in the "Golden Corn Belt" of the Yellow River Basin, and it adopts the national patented "Six-Layer Fresh-Keeping Production Process" to ensure the safety, greenness and health of its products. In March 2026, Xiwang Food deeply participated in the revision of the national standard for olive oil, leading quality with standards, empowering the development of the high-end healthy edible oil track, and demonstrating its industrial technological strength and quality control capabilities.Xiwang Group has always regarded technological innovation as the core driving force. It has built a number of national, provincial and municipal R&D and innovation platforms, including the National Industrial Technology Innovation Center for Corn Deep Processing, National Laboratory, and Shandong Provincial Engineering Research Center for Food Nutrition and Active Health. To date, it has obtained 89 nationally authorized patents, including more than 10 high-value invention patents. On January 22, 2026, a research team from the China Grain Research and Training Center visited Xiwang and highly recognized the demonstration and leading role of its full-industry-chain model in promoting the large-scale, intensive, green and high-end development of the characteristic agricultural product processing industry.At the same time, the group has cooperated with universities such as Shandong Agricultural University to carry out special training on "High-Yield and High-Efficiency Summer Corn Cultivation Technology", solving key problems such as poor stress resistance and low yield of corn varieties, and helping the implementation of the rural revitalization strategy.As a National Green Factory, Xiwang Group took the lead in obtaining the first "carbon label" in the edible oil industry, passed the clean production certification, and adhered to the path of ecological priority and green development. On February 9, 2026, a delegation from Xiwang Group went to Huaxian County, Henan Province to hold in-depth negotiations on the "Annual 1 Million Ton Corn Processing Circular Economy (Zero-Carbon) Industrial Park Project", reaching a number of consensuses on details such as project financing, cooperation models and investment guarantees, marking an important step for Xiwang in the field of green and low-carbon development.The project will integrate internationally advanced corn deep processing technology and zero-carbon circular concepts to achieve efficient resource utilization and near-zero pollutant emissions. It is expected to achieve an annual sales income of over 10 billion yuan and drive more than 2,000 jobs after completion, injecting new momentum into regional economic development.Xiwang Group adheres to the principle of "building a brand with quality and expanding the market with the brand". The "Xiwang" trademark has been rated as a China Famous Trademark, and has been selected as a representative brand of "Good Products Shandong" for many consecutive years, and has become the designated edible oil for the 11th National Games. In March 2026, the sports nutrition sector of Xiwang Food launched Platinum NMN Capsules, which meet the upgrading needs of consumers' health with functions such as scientific anti-aging, improving metabolism and enhancing physical function, further enriching the brand matrix.In terms of global market expansion, platforms such as Xiwang International Trade (Qingdao) Co., Ltd. have actively laid out the global supply chain, with raw material procurement covering major olive oil producing areas such as Spain, and products exported to more than 30 countries and regions in Europe, America, Southeast Asia, etc., promoting "Xiwang Manufacturing" to the world stage.Facing the "14th Five-Year Plan" and beyond, Xiwang Group will rely on the National Industrial Technology Innovation Center for Corn Deep Processing to deepen industrial chain extension, strengthen innovation chain drive, and promote value chain upgrading, focusing on three strategic directions: the construction of zero-carbon industrial parks, the R&D of high-end special steel materials, and the upgrading of healthy food. Wang Yong, Chairman of the Group, said: "Xiwang will always adhere to the original aspiration of serving the country through industry, forge quality with craftsmanship, lead development through innovation, and contribute Xiwang's strength to ensuring national food security, promoting green industrial transformation, and boosting the high-quality development of the regional economy." CONTACT INFORMATIONWebsite:https://www.xiwang-pharmaceutical.com/Phone:+8615371019725Email:sales7@boxa-chem.com

xiwang pharmaceutical co.,Itd address
xiwang pharmaceutical co.,Itd address

 Finding the correct address for any pharmaceutical company feels a bit like checking the label on a medicine packet before deciding if you trust what’s inside. Xiwang Pharmaceutical Co., Ltd. keeps popping up when searching for pharmaceutical solutions out of China, but people often find themselves chasing after a concrete address that seems tricky to pin down. In my own experience, missing or incorrect business addresses rarely signal anything good. The world’s full of companies trying to stand out with cutting-edge products or global ambitions, but there’s a big difference between a company that’s transparent about its operations and one that leaves you guessing. In a sector where credibility and traceability are literally matters of life and health, the simple ability to verify a company’s physical location holds a surprising amount of weight. Investors, researchers, or importers all have a stake in knowing exactly where their products come from, who made them, and who stands behind the shipments—a simple street address unlocks a sense of accountability even before the first purchase order is drawn up. Reporting shows that many firms across the pharmaceutical industry have made deliberate moves towards greater transparency and compliance as global scrutiny grows. Pharmaceutical companies in China, for example, have faced a unique blend of opportunities and challenges, given the country’s complicated regulatory landscape and its meteoric growth in the global active pharmaceutical ingredients trade. Having walked the factory floor in several Chinese provinces myself, it’s clear some firms welcome visits from buyers or regulatory agencies, eager to demonstrate a willingness to comply with both local and international expectations. Others keep things vague and distant, listing only general regions or city names on their public-facing channels. The difference always shows up in the little things: companies that openly provide detailed addresses usually back them up with photographs of their premises, legal business licenses, and a sense of pride in their position within an industrial park or business district, rather than hiding behind PO boxes or generic “Development Zone” language. Choosing to work with a company whose corporate address amounts to a dead end often invites unnecessary risk. Around the world, the pharmaceutical supply chain faces repeated incidents of adulteration, mislabeled products, or outright fraud. Health authorities try to stamp this out, but nothing substitutes for local insight and verifiable contacts on the ground. I’ve come across cases where an order ends up delayed on the docks, or a regulatory certificate turns out to be invalid, just because nobody could actually verify who was behind the shipment. The lack of an address not only frustrates customs or quality control checks, but also complicates logistics and damages business relationships. Trust, among buyers or end users, rarely recovers from those stories, and with good reason. It’s nearly impossible to enforce contracts or pursue restitution when a supplier's location stays hidden or seems to change every few months. Practical steps to fix the situation start with basic due diligence. Verifying a supplier’s legal registration with regulatory bodies or cross-referencing addresses against business registries remain key habits in my own work. People now look for third-party certifications or inspection records posted online, but nothing beats being able to phone the company front desk or send an associate to knock on the factory gate. In an era shaped by digital platforms, even small pharmaceutical manufacturers are being brought under the umbrella of government databases and mapping services. QR codes on packaging or instant access to registration information can bridge some of the information gaps, but buyers still benefit most from suppliers who practice radical openness—posting full business addresses, owner names, and accurate contact details without hesitation. Countries with strong regulatory environments already demand this. Adopting these norms globally would help raise the bar and make it harder for unreliable operators to hide in plain sight. While an address forms the bedrock of credibility, it’s only the start. Audits, visits, and cooperative agreements go much further in forming trustworthy partnerships, especially in pharmaceutical supply lines where breakdowns can have far-reaching health impacts. On a personal level, I learned to view every supplier interaction as an exercise in building a relationship, starting with something as concrete as a street address and growing into broader discussions of quality, documentation, and planning. The best companies usually meet requests for transparency with open arms, eager to showcase their legitimacy and join the larger conversation about safe, effective drug supply. Without these underpinnings, nobody wins—not manufacturers, not regulators, not patients halfway across the world waiting for the right medicine. Transparency, starting with something as basic and essential as a physical address, gives everyone a better shot at a fair, workable system. CONTACT INFORMATIONWebsite:https://www.xiwang-pharmaceutical.com/Phone:+8615371019725Email:sales7@boxa-chem.com

Xiwang Pharmaceutical Co., Ltd. Dextrose
Xiwang Pharmaceutical Co., Ltd. Dextrose

Xiwang Pharmaceutical Co., Ltd. announced that its core product, glucose raw material, has successfully passed the EU CEP (Certificate of Suitability) certification, marking its official access to the EU market and a significant leap forward in its international competitiveness. This is another important breakthrough for Xiwang Pharmaceutical in the high-end international market, following its certifications by the US FDA and Japan PMDA.As a leading enterprise in the domestic starch sugar raw material industry, Xiwang Pharmaceutical has focused on the research and development and production of glucose series products for over 20 years. With an annual production capacity of 300,000 tons of glucose raw material, it is one of the world's largest glucose production bases. The company's glucose products cover multiple varieties, including anhydrous glucose, monohydrate glucose, and oral glucose, with a purity of 99.5%-99.9%, and are widely used in pharmaceuticals, food, and chemical industries. The glucose raw material that has now passed CEP certification adopts internationally advanced fully enclosed production technology, achieving full-chain quality control from corn raw materials to finished products. Key quality indicators all meet or exceed European Pharmacopoeia standards.A quality manager at Xiwang Pharmaceutical stated, "The successful CEP certification is a high recognition of the quality of Xiwang Pharmaceutical's glucose products and its production management system. In the future, the company will continue to increase investment in research and development, optimize its product structure, and further expand into international markets, allowing Xiwang glucose products to benefit more customers worldwide." It is understood that Xiwang Pharmaceutical's glucose raw materials have been exported to more than 50 countries and regions worldwide, establishing a high-quality image for "Made in China" in the international market.This successful certification not only enhances Xiwang Pharmaceutical Co., Ltd.'s position in the global pharmaceutical supply chain but also provides an important reference for the Chinese glucose raw material industry to participate in international competition, demonstrating the strong capabilities of Chinese pharmaceutical manufacturing.

Xiwang Foodstuffs Releases Health Strategy
Xiwang Foodstuffs Releases Health Strategy

Xiwang Foodstuffs Co., Ltd. recently held its 2025 strategic launch conference, officially releasing its "Healthy China • Xiwang Action" strategic plan. The plan proposes a dual-engine model of "edible oil + sports nutrition" to become a benchmark enterprise in the national healthy food industry. As the first corn oil company listed on the A-share market in China, Xiwang Foodstuffs has consistently led the development of China's healthy edible oil industry since being awarded the title of "China's Corn Oil City" by the China Food Industry Association in 2010.In the edible oil sector, Xiwang Foodstuffs will focus on the core advantages of corn germ oil, launching a dual-series product line of "fresh germ + functional" products. It will strengthen its "6-fold preservation lock" technology to ensure that products retain more natural vitamin E and phytosterols. The company plans to increase the sales share of small-packaged edible oils to 70% by 2026, further consolidating its market share of over 30% in corn oil. Simultaneously, Xiwang Foodstuffs will increase its R&D investment in healthy oils such as sunflower seed oil and olive oil to meet the diverse health needs of consumers.In the sports nutrition sector, Xiwang Foodstuffs leverages its internationally renowned brands such as MuscleTech and SixStar to launch a series of products tailored to the physiques of Chinese consumers, covering multiple areas including weight management and sports recovery. The company plans to add 500 sports nutrition product counters by 2025, building an integrated online and offline omnichannel marketing network.The General Manager of Xiwang Foodstuffs stated, "Xiwang Foodstuffs will always uphold its mission of 'Boosting the Health of the Chinese People,' providing consumers with higher-quality and healthier food choices through technological innovation and product upgrades, contributing to the construction of a healthy China."

Xiwang International Company Limited is building a new global supply chain ecosystem.
Xiwang International Company Limited is building a new global supply chain ecosystem.

Xiwang International Company Limited recently announced the completion of its global supply chain system upgrade, establishing an international trade network centered in Qingdao and covering five continents, providing strong impetus for the high-quality development of Xiwang Group. As the core trading platform under Xiwang Group, Xiwang International has developed into a comprehensive international trading enterprise integrating raw material procurement, product sales, and logistics distribution since its establishment in 2003.This supply chain upgrade focused on strengthening three core capabilities: first, global resource integration capabilities, ensuring a stable supply of core raw materials such as corn, soybeans, and iron ore powder through long-term strategic partnerships with major suppliers in countries such as Brazil, Australia, and Russia; second, intelligent logistics management capabilities, introducing blockchain technology to achieve full traceability of goods and improve logistics efficiency by 30%; and third, risk control capabilities, establishing a global commodity price monitoring system to effectively mitigate market volatility risks.Xiwang International's business scope covers multiple fields including agricultural products, mineral energy, steel, and chemical products, with an annual trade volume exceeding 10 billion yuan. In the agricultural trade sector, the company has become one of the largest corn importers in China, providing a stable raw material guarantee for Xiwang Group's corn deep processing industry. In the mineral and energy sector, the company imports over ten million tons of iron ore powder annually, supporting the development of Xiwang Special Steel Industry.The General Manager of Xiwang International stated, "Xiwang International Company Limited will take this supply chain upgrade as an opportunity to further expand its international market reach, improve the efficiency of global resource allocation, and contribute to Xiwang Group's goal of becoming a world-class enterprise." In the future, Xiwang International will also develop cross-border e-commerce business and explore an innovative development model combining "trade + finance + technology."